Literature DB >> 8881901

Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis.

J Berth-Jones1.   

Abstract

The Six Area, Six Sign Atopic Dermatitis severity score has proved to be a simple and effective system for recording and monitoring disease activity in atopic dermatitis. The score is obtained by grading six signs (erythema, exudation, excoriation, dryness, cracking and lichenification), each on a scale of () (absent), 1 (mild), 2 (moderate), or 3 (severe), at each of six sites; arms, hands, legs, feet, head and neck, trunk. The maximum score is 108.

Entities:  

Mesh:

Year:  1996        PMID: 8881901     DOI: 10.1111/j.1365-2133.1996.tb00706.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  29 in total

1.  Allergen-specific CD8(+) T cells and atopic disease.

Authors:  Suranjith L Seneviratne; Louise Jones; Abigail S King; Antony Black; Sheila Powell; Andrew J McMichael; Graham S Ogg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  [Measurement of disease severity in dermatology].

Authors:  S Deckert; C Apfelbacher; J Schmitt
Journal:  Hautarzt       Date:  2015-09       Impact factor: 0.751

3.  The effects of Mycobacteria vaccae derivative on allergen-specific responses in children with atopic dermatitis.

Authors:  J A Dunstan; S Brothers; J Bauer; M Hodder; M M Jaksic; M I Asher; S L Prescott
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

4.  Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema.

Authors:  K S Thomas; S Armstrong; A Avery; A Li Wan Po; C O'Neill; S Young; H C Williams
Journal:  BMJ       Date:  2002-03-30

5.  Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis.

Authors:  Abeer Hodeib; Zeinab Abd El-Samad; Hesham Hanafy; Amani Abd El-Latief; Amal El-Bendary; Azza Abu-Raya
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

6.  Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial.

Authors:  A Takwale; E Tan; S Agarwal; G Barclay; I Ahmed; K Hotchkiss; J R Thompson; T Chapman; J Berth-Jones
Journal:  BMJ       Date:  2003-12-13

Review 7.  Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids.

Authors:  Roman Schiffner; Julia Schiffner-Rohe; Michael Landthaler; Wilhelm Stolz
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 8.  Treatment of childhood eczema.

Authors:  Håkan Granlund
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Interleukin-4 promotes human CD8 T cell expression of CCR7.

Authors:  Suranjith L Seneviratne; Antony P Black; Louise Jones; Kati di Gleria; Abigail S Bailey; Graham S Ogg
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

10.  Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Authors:  Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2021-08-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.